Loading…
Loading…
Illumina Inc
NASDAQ · Stock Profile · Market Cap $18.79B
Current Price
$122.95
+1.75%GoodMoat Value
$125.25
1.9% undervaluedTrading 2% below its estimated fair value of $125.25.
Forward estimates use 50.0% FCF growth (CAGR)
Net Debt: 1.1B
1.1B
FY24
1.1B
FY24
4.4B
FY24
1.0B
FY25
1.1B
FY25
1.1B
FY25
4.3B
FY25
—
FY24
705M
FY24
—
FY24
131M
FY25
235M
FY25
150M
FY25
850M
FY25
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
Country
California, USA
Earnings per share grew at a 50.0% CAGR.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →This stock does not currently pay a dividend.
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
Country
California, USA